ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 60 filers reported holding ENZO BIOCHEM INC in Q4 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $39 | -11.4% | 17,473 | -17.3% | 0.00% | – |
Q2 2022 | $44 | -99.9% | 21,122 | -27.2% | 0.00% | – |
Q1 2022 | $84,000 | -12.5% | 29,025 | -3.4% | 0.00% | – |
Q4 2021 | $96,000 | -40.0% | 30,041 | -33.5% | 0.00% | – |
Q3 2021 | $160,000 | -33.3% | 45,163 | -40.3% | 0.00% | – |
Q2 2021 | $240,000 | -10.8% | 75,646 | -3.2% | 0.00% | – |
Q1 2021 | $269,000 | +83.0% | 78,139 | +34.1% | 0.00% | – |
Q4 2020 | $147,000 | -23.0% | 58,278 | -35.7% | 0.00% | – |
Q3 2020 | $191,000 | -25.7% | 90,675 | -21.0% | 0.00% | – |
Q2 2020 | $257,000 | +65.8% | 114,712 | +87.2% | 0.00% | – |
Q1 2020 | $155,000 | +23.0% | 61,294 | +27.2% | 0.00% | – |
Q4 2019 | $126,000 | -3.8% | 48,183 | +32.4% | 0.00% | – |
Q3 2019 | $131,000 | -67.7% | 36,403 | -69.7% | 0.00% | – |
Q2 2019 | $406,000 | +75.8% | 120,326 | +42.3% | 0.00% | – |
Q1 2019 | $231,000 | -18.9% | 84,560 | -17.5% | 0.00% | – |
Q4 2018 | $285,000 | -25.6% | 102,467 | +10.3% | 0.00% | – |
Q3 2018 | $383,000 | -41.3% | 92,880 | -26.2% | 0.00% | – |
Q2 2018 | $653,000 | -46.0% | 125,915 | -43.0% | 0.00% | – |
Q1 2018 | $1,210,000 | -0.9% | 220,814 | +47.4% | 0.00% | – |
Q4 2017 | $1,221,000 | -18.3% | 149,854 | +5.1% | 0.00% | – |
Q3 2017 | $1,494,000 | -34.4% | 142,623 | -30.8% | 0.00% | -100.0% |
Q2 2017 | $2,277,000 | +127.5% | 206,234 | +72.4% | 0.00% | – |
Q1 2017 | $1,001,000 | +14.0% | 119,639 | -5.4% | 0.00% | – |
Q4 2016 | $878,000 | +53.8% | 126,524 | +12.9% | 0.00% | – |
Q3 2016 | $571,000 | +178.5% | 112,099 | +225.9% | 0.00% | – |
Q2 2016 | $205,000 | -74.1% | 34,396 | -80.2% | 0.00% | – |
Q1 2016 | $790,000 | +65.3% | 173,561 | +63.4% | 0.00% | – |
Q4 2015 | $478,000 | +8.4% | 106,239 | -23.6% | 0.00% | – |
Q3 2015 | $441,000 | -52.1% | 138,977 | -54.3% | 0.00% | – |
Q2 2015 | $921,000 | +254.2% | 303,999 | +245.3% | 0.00% | – |
Q1 2015 | $260,000 | -27.6% | 88,044 | +8.8% | 0.00% | – |
Q4 2014 | $359,000 | -23.6% | 80,918 | -11.2% | 0.00% | – |
Q3 2014 | $470,000 | -10.6% | 91,173 | -9.1% | 0.00% | – |
Q2 2014 | $526,000 | -4.9% | 100,278 | -24.6% | 0.00% | – |
Q1 2014 | $553,000 | +27.7% | 132,978 | -10.3% | 0.00% | – |
Q4 2013 | $433,000 | +1.9% | 148,329 | -12.0% | 0.00% | – |
Q3 2013 | $425,000 | +20.7% | 168,583 | -0.4% | 0.00% | – |
Q2 2013 | $352,000 | -28.7% | 169,211 | -7.5% | 0.00% | – |
Q4 2012 | $494,000 | -2.2% | 182,850 | -26.2% | 0.00% | – |
Q3 2012 | $505,000 | +11.2% | 247,761 | -8.8% | 0.00% | – |
Q2 2012 | $454,000 | +1465.5% | 271,768 | +2430.0% | 0.00% | – |
Q1 2012 | $29,000 | – | 10,742 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |